Table of Contents: Oncotarget’s Volume 12, Issue #2

Read short summaries of the latest oncology-focused peer-reviewed literature published bi-weekly by Oncotarget.

Table Of Contents
Listen to an audio version of this post

Oncotarget’s Volume 12, Issue #2

New Publications

Cover Paper: Improved therapeutic efficacy of unmodified anti-tumor antibodies by immune checkpoint blockade and kinase targeted therapy in mouse models of melanoma

Origin: New York, United States

Institutions: Columbia University

Quote: “We postulate that combining anti-tumor antibodies with standard-of-care strategies such as immune checkpoint blockade or targeted therapy, will improve therapeutic outcomes in cancer.”

Research Perspective: Clinical application of liquid biopsies to detect somatic BRCA1/2 mutations and guide potential therapeutic intervention for patients with metastatic breast cancer

Origin: Massachusetts, United States

Institution: Harvard Medical School

Quote: “In this article, we discuss recent studies using cell-free DNA testing to identify and classify somatic BRCA1/2 mutations in metastatic breast cancer, and potential future applications for the treatment of metastatic breast cancer.

Research Paper: A priori prediction of response in multicentre locally advanced breast cancer (LABC) patients using quantitative ultrasound and derivative texture methods

Origin: Ontario, Canada; Texas, United States

Institution: Sunnybrook Health Sciences Centre, University of Toronto, Sunnybrook Research Institute, University Health Network, Western University, Ryerson University, University of Texas

Quote: “We develop a multi-centric response predictive model using QUS spectral parametric imaging and novel texture-derivate methods for determining tumour responses to neoadjuvant chemotherapy (NAC) prior to therapy initiation.

Research Paper: Harmonized pretreatment quantitative volume-based FDG-PET/CT parameters for prognosis of stage I–III breast cancer: Multicenter study

Origin: Hyogo, Maebashi, Osaka, Tokyo, Japan

Institutions: Hyogo College of Medicine, Nippon Medical School Hospital, National Cancer Center Hospital, Kinki University Faculty of Medicine, Gunma Prefectural College of Health Sciences

Quote: “This study investigated harmonized pretreatment volume-based quantitative FDG-PET/CT parameters in breast cancer patients for prognostic value.

ReviewReversing oncogenic transformation with iron chelation

Origin: Newcastle upon Tyne, United Kingdom

Institution: Northumbria University

Quote: “This review will evaluate the impact of iron chelation on cancer cell survival and the underlying mechanisms of action.”

Case Report: Standardized diagnostic algorithm for spitzoid lesions aids clinical decision-making and management: a case series from a Swiss reference center

Origin: Zurich, Switzerland

Institution: University Hospital Zurich, Children’s Hospital Zurich

Quote: “We illustrate how clinical, histological and molecular features contribute to an optimized management plan in these critical situations and present a possible algorithm for the assessment of spitzoid neoplasms.

Click here to read Oncotarget’s Volume 12, Issue #2.

Oncotarget is a unique platform designed to house scientific studies in a journal format that is available for anyone to read—without a paywall making access more difficult. This means information that has the potential to benefit our societies from the inside out can be shared with friends, neighbors, colleagues, and other researchers, far and wide.

For media inquiries, please contact

Leave a Reply

Your email address will not be published. Required fields are marked *